IDEXX Cash and Equivalents vs Operating Expenses Analysis

IDXX Stock  USD 539.57  8.97  1.69%   
Trend analysis of IDEXX Laboratories balance sheet accounts such as Total Current Liabilities of 999.1 M or Total Stockholder Equity of 1.6 B provides information on IDEXX Laboratories' total assets, liabilities, and equity, which is the actual value of IDEXX Laboratories to its prevalent stockholders. By breaking down trends over time using IDEXX Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

About IDEXX Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of IDEXX Laboratories at a specified time, usually calculated after every quarter, six months, or one year. IDEXX Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of IDEXX Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which IDEXX currently owns. An asset can also be divided into two categories, current and non-current.

IDEXX Laboratories Balance Sheet Chart

IDEXX Laboratories Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how IDEXX Laboratories uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, IDEXX Laboratories' Cash And Short Term Investments are fairly stable compared to the past year. Net Receivables is likely to rise to about 480.3 M in 2024, whereas Net Debt is likely to drop slightly above 255.9 M in 2024.

Total Assets

Total assets refers to the total amount of IDEXX Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in IDEXX Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on IDEXX Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of IDEXX Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.Enterprise Value Multiple is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 194 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.9B2.0B2.2B2.3B
Total Revenue3.2B3.4B3.7B3.8B

IDEXX Laboratories fundamental ratios Correlations

0.970.750.730.980.330.910.950.630.980.840.480.99-0.320.970.97-0.920.820.960.770.720.630.110.90.60.54
0.970.70.650.990.390.860.970.520.980.880.360.98-0.420.920.95-0.890.850.890.860.70.650.040.880.580.54
0.750.70.190.750.770.520.770.270.690.460.480.72-0.280.760.8-0.650.920.780.730.570.930.730.490.670.67
0.730.650.190.64-0.390.890.590.750.720.730.330.710.050.740.65-0.750.20.690.190.61-0.06-0.390.820.250.14
0.980.990.750.640.420.860.960.520.990.850.360.99-0.390.940.96-0.90.860.90.850.690.680.10.860.620.58
0.330.390.77-0.390.420.00.47-0.290.320.150.10.35-0.520.310.41-0.220.790.310.720.20.910.740.070.470.51
0.910.860.520.890.860.00.840.670.920.850.30.9-0.190.930.9-0.970.550.830.50.760.31-0.110.890.410.33
0.950.970.770.590.960.470.840.40.970.850.30.97-0.430.930.95-0.890.860.870.830.740.690.150.870.580.53
0.630.520.270.750.52-0.290.670.40.520.390.760.550.180.560.52-0.550.270.730.230.360.11-0.140.610.40.32
0.980.980.690.720.990.320.920.970.520.90.310.99-0.370.960.97-0.940.790.890.780.740.590.030.90.550.5
0.840.880.460.730.850.150.850.850.390.90.090.88-0.320.830.82-0.830.590.70.620.680.35-0.190.820.380.33
0.480.360.480.330.360.10.30.30.760.310.090.390.080.390.34-0.230.410.70.310.120.420.30.380.430.39
0.990.980.720.710.990.350.90.970.550.990.880.39-0.380.960.96-0.910.820.920.80.70.620.060.90.570.51
-0.32-0.42-0.280.05-0.39-0.52-0.19-0.430.18-0.37-0.320.08-0.38-0.27-0.320.3-0.5-0.22-0.630.11-0.48-0.02-0.340.130.2
0.970.920.760.740.940.310.930.930.560.960.830.390.96-0.270.97-0.930.770.920.680.780.590.170.870.570.5
0.970.950.80.650.960.410.90.950.520.970.820.340.96-0.320.97-0.960.830.90.760.80.670.210.830.60.55
-0.92-0.89-0.65-0.75-0.9-0.22-0.97-0.89-0.55-0.94-0.83-0.23-0.910.3-0.93-0.96-0.68-0.82-0.62-0.79-0.48-0.06-0.84-0.49-0.42
0.820.850.920.20.860.790.550.860.270.790.590.410.82-0.50.770.83-0.680.80.940.510.950.490.60.650.65
0.960.890.780.690.90.310.830.870.730.890.70.70.92-0.220.920.9-0.820.80.710.640.660.220.840.620.56
0.770.860.730.190.850.720.50.830.230.780.620.310.8-0.630.680.76-0.620.940.710.40.850.230.610.550.55
0.720.70.570.610.690.20.760.740.360.740.680.120.70.110.780.8-0.790.510.640.40.350.150.640.650.63
0.630.650.93-0.060.680.910.310.690.110.590.350.420.62-0.480.590.67-0.480.950.660.850.350.690.370.590.62
0.110.040.73-0.390.10.74-0.110.15-0.140.03-0.190.30.06-0.020.170.21-0.060.490.220.230.150.69-0.180.430.47
0.90.880.490.820.860.070.890.870.610.90.820.380.9-0.340.870.83-0.840.60.840.610.640.37-0.180.380.28
0.60.580.670.250.620.470.410.580.40.550.380.430.570.130.570.6-0.490.650.620.550.650.590.430.380.97
0.540.540.670.140.580.510.330.530.320.50.330.390.510.20.50.55-0.420.650.560.550.630.620.470.280.97
Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.8B2.3B2.4B2.7B3.3B3.4B
Other Current Liab322.9M415.6M458.9M433.7M478.7M502.6M
Total Current Liabilities725.3M582.8M763.6M1.2B951.5M999.1M
Total Stockholder Equity177.5M632.1M690.0M608.7M1.5B1.6B
Property Plant And Equipment Net533.8M555.2M587.7M649.5M702.2M737.3M
Net Debt897.3M524.6M779.2M1.2B493.9M255.9M
Retained Earnings1.6B2.2B2.9B3.6B4.4B4.7B
Accounts Payable72.2M74.6M116.1M110.2M110.6M116.2M
Cash90.3M383.9M144.5M112.5M453.9M476.6M
Non Current Assets Total1.2B1.2B1.5B1.6B1.8B1.9B
Non Currrent Assets Other299.0M337.2M397.4M425.6M448.5M470.9M
Cash And Short Term Investments90.3M383.9M144.5M112.5M453.9M476.6M
Net Receivables269.3M331.4M368.3M400.6M457.4M480.3M
Common Stock Shares Outstanding87.5M86.7M86.6M84.6M84.0M94.9M
Liabilities And Stockholders Equity1.8B2.3B2.4B2.7B3.3B3.4B
Inventory195.0M209.9M269.0M367.8M380.3M399.3M
Other Current Assets125.0M137.5M173.8M220.5M203.6M213.8M
Other Stockholder Equity(1.4B)(1.5B)(2.2B)(2.9B)(2.9B)(2.8B)
Total Liab1.7B1.7B1.7B2.1B1.8B1.9B
Total Current Assets679.6M1.1B955.7M1.1B1.5B1.6B
Non Current Liabilities Total929.3M1.1B983.6M902.2M823.8M865.0M
Intangible Assets58.5M52.5M99.0M97.7M84.5M74.5M
Short Long Term Debt Total987.7M908.5M923.7M1.3B947.9M995.3M
Short Term Debt288.8M50.0M148.5M654.0M325.0M208.6M
Property Plant And Equipment Gross614.5M646.3M1.3B649.5M1.6B1.7B
Accumulated Other Comprehensive Income(46.2M)(53.6M)(53.5M)(77.8M)(71.2M)(67.6M)
Common Stock Total Equity10.6M10.6M10.7M10.7M12.3M9.0M
Common Stock10.6M10.6M10.7M10.7M10.8M9.2M
Other Assets240.2M676.7M893.9M387.5M445.6M467.9M
Treasury Stock(2.3B)(2.6B)(2.8B)(3.6B)(3.2B)(3.1B)
Property Plant Equipment533.8M555.2M587.7M649.5M746.9M784.2M
Current Deferred Revenue41.5M42.6M40.0M37.9M37.2M25.0M
Good Will239.7M243.3M359.3M361.8M366.0M206.0M
Other Liab162.8M220.5M208.4M106.6M122.6M83.3M
Long Term Debt698.9M858.5M775.2M694.4M622.9M380.8M
Net Tangible Assets(120.7M)336.2M690.0M149.3M134.3M141.1M
Noncontrolling Interest In Consolidated Entity264K280K352K707K813.1K853.7K
Retained Earnings Total Equity1.6B2.2B2.9B3.6B4.1B4.3B
Long Term Debt Total698.9M858.5M775.2M694.4M798.5M502.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.121
Earnings Share
10.09
Revenue Per Share
44.073
Quarterly Revenue Growth
0.088
Return On Assets
0.2283
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.